Repare signs out-licensing deal with DCx Biotherapeutics
Repare Therapeutics has entered into an out-licensing agreement with Canadian biotechnology firm DCx for discovery platforms and IP.
Repare Therapeutics has entered into an out-licensing agreement with Canadian biotechnology firm DCx for discovery platforms and IP.
What's Your Reaction?
